Hints and tips:
Social media giant joins Apple and Microsoft in offering payout to placate investors concerned about big R&D spend
...helped by a few big successes such as insurance group Skyward Specialty, which has risen 125 per cent since listing a year ago, and Rayzebio, which is up 244 per cent, driven by news last month that Bristol Myers...
...Still, that has not stopped investors from fretting about pipeline replacement at companies such as Bristol Myers Squibb (BMS), Sanofi and Roche....
...Affairs, Claude and Lore Kelly Professor of European Studies, Princeton University, Princeton, NJ, USIMF’s focus on pollution subsidies is misleading / From Philip Rossetti, Senior Fellow for Energy Policy, R...
...Bristol-Myers Squibb earlier this month agreed to buy Turning Point Therapeutics, which is developing a new cancer drug, for $4.1bn....
...Riley located the arch via a book called Whales’ Bones of the British Isles, a directory of whale fragments self-published by an enthusiast named Nicholas Redman....
...Nevertheless, as Nicholas Stern has noted in the FT, the UK needs higher public and private investment. It also needs to spend more on defence. That does not allow for tax cuts....
...Cancer, stroke and diabetes medications made by Merck, Johnson & Johnson and Bristol Myers Squibb are among the first tranche of medications selected for negotiation....
...Bristol Myers Squibb has warned of similar moves. Investors value future drugs according to their chances of success and potential market size....
...Initial Irish investments by Pfizer and Bristol Myers Squibb more than a half century ago encouraged other multinationals to follow, he said....
...From meetings with Sam Altman to a secretive “Project R”, SoftBank boss Masayoshi Son is looking to make a comeback after years and years of bad bets, The Information reports. CEO or CEOs?...
...April 10 to October 6; further information and tickets here Performance ‘Dangerous Days’, Colony Theatre Premiere of Miami New Drama’s adaptation of journalist and author Nicholas Griffin’s acclaimed...
...The UK’s share of pharmaceuticals R&D has fallen, from 7.7 per cent in 2012 to 4.2 per cent in 2020....
...Sidley Austin has hired Kirkland & Ellis’ Nicholas Cassin as partner in its investment funds practice, based in New York....
...Additional reporting by Nicholas Megaw...
...We should aim to at least double R&D as a share of GDP (public and private funding together)....
...Foreign investors have driven the gains, pouring R$75bn ($15bn) so far this year into Brazil’s B3 stock exchange alone, according to analysts at Bank of America, even as local investors exited equities in...
...Additional reporting by Nicholas Megaw in New York...
...That is still far above the price that prevailed before day traders on Reddit, some of whom amassed on the r/WallStreetBets message board, helped spark a ‘short squeeze’ to inflict pain on hedge funds betting...
...The CRF’s research, published in May, echoed many of the findings of pioneering work by economics professor Nicholas Bloom at Stanford, who has been at the forefront of research into the effects of homeworking...
...The Harrow-educated Blackwell was “Chris Whiteworst” to Peter Tosh, the firebrand Wailer member whose story is told in Nicholas Campbell’s 1992 film Steppin’ Razor: Red X....
...Additional reporting by Carolina Ingizza and Nicholas Megaw...
...The chief executive of Bristol Myers Squibb called the US government’s support for the temporary waiver of Covid-19 vaccine patents “very concerning”, adding to the outcry from the pharmaceutical industry...
...[MICRON ADVERTISEMENT]Micron’s planned investment of over $150bn in manufacturing and R&D, combined with sustained government support . . ....
...British R&D spending also remains a concern. In 2019, private and public investment in the UK totalled £38.5bn, according to the latest figures from the Office for National Statistics....
International Edition